After the FDA's Public Hearing on CBD, Industry Efforts Turn Towards Congress
On July 2, 2019, Carolina published After the FDA’s Public Hearing on CBD, Industry Efforts Turn Towards Congress. For more information, please contact Ms. Wirth.
We welcome your interest in AGG. However, we cannot represent you nor can we treat unsolicited information as confidential until we know that doing so will not create a conflict of interest. Accordingly, please DO NOT send information about any matter unless you have a written engagement letter from us stating that we represent you as a client.